Literature DB >> 23579487

Cellular insulin resistance disrupts leptin-mediated control of neuronal signaling and transcription.

Anaies Nazarians-Armavil1, Jonathan A Menchella, Denise D Belsham.   

Abstract

Central resistance to the actions of insulin and leptin is associated with the onset of obesity and type 2 diabetes mellitus, whereas leptin and insulin signaling is essential for both glucose and energy homeostasis. Although it is known that leptin resistance can lead to attenuated insulin signaling, whether insulin resistance can lead to or exacerbate leptin resistance is unknown. To investigate the molecular events underlying crosstalk between these signaling pathways, immortalized hypothalamic neuronal models, rHypoE-19 and mHypoA-2/10, were used. Prolonged insulin exposure was used to induce cellular insulin resistance, and thereafter leptin-mediated regulation of signal transduction and gene expression was assessed. Leptin directly repressed agouti-related peptide mRNA levels but induced urocortin-2, insulin receptor substrate (IRS)-1, IRS2, and IR transcription, through leptin-mediated phosphatidylinositol 3-kinase/Akt activation. Neuronal insulin resistance, as assessed by attenuated Akt phosphorylation, blocked leptin-mediated signal transduction and agouti-related peptide, urocortin-2, IRS1, IRS2, and insulin receptor synthesis. Insulin resistance caused a substantial decrease in insulin receptor protein levels, forkhead box protein 1 phosphorylation, and an increase in suppressor of cytokine signaling 3 protein levels. Cellular insulin resistance may cause or exacerbate neuronal leptin resistance and, by extension, obesity. It is essential to unravel the effects of neuronal insulin resistance given that both peripheral, as well as the less widely studied central insulin resistance, may contribute to the development of metabolic, reproductive, and cardiovascular disorders. This study provides improved understanding of the complex cellular crosstalk between insulin-leptin signal transduction that is disrupted during neuronal insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579487      PMCID: PMC5415275          DOI: 10.1210/me.2012-1338

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  74 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  Selective insulin and leptin resistance in metabolic disorders.

Authors:  A Christine Könner; Jens C Brüning
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

Review 3.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

4.  Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3.

Authors:  John W M Creemers; Lynn E Pritchard; Amy Gyte; Philippe Le Rouzic; Sandra Meulemans; Sharon L Wardlaw; Xiaorong Zhu; Donald F Steiner; Nicola Davies; Duncan Armstrong; Catherine B Lawrence; Simon M Luckman; Catherine A Schmitz; Rick A Davies; John C Brennand; Anne White
Journal:  Endocrinology       Date:  2005-12-29       Impact factor: 4.736

5.  Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.

Authors:  Jennifer W Hill; Kevin W Williams; Chianping Ye; Ji Luo; Nina Balthasar; Roberto Coppari; Michael A Cowley; Lewis C Cantley; Bradford B Lowell; Joel K Elmquist
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

6.  Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons.

Authors:  Denise D Belsham; Laura J Fick; Prasad S Dalvi; Maria-Luisa Centeno; Jennifer A Chalmers; Paul K P Lee; Yangyang Wang; Daniel J Drucker; Margaret M Koletar
Journal:  FASEB J       Date:  2009-08-24       Impact factor: 5.191

7.  Hyperinsulinemia drives diet-induced obesity independently of brain insulin production.

Authors:  Arya E Mehran; Nicole M Templeman; G Stefano Brigidi; Gareth E Lim; Kwan-Yi Chu; Xiaoke Hu; Jose Diego Botezelli; Ali Asadi; Bradford G Hoffman; Timothy J Kieffer; Shernaz X Bamji; Susanne M Clee; James D Johnson
Journal:  Cell Metab       Date:  2012-12-05       Impact factor: 27.287

Review 8.  CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.

Authors:  Merly C Vogt; Jens C Brüning
Journal:  Trends Endocrinol Metab       Date:  2012-12-19       Impact factor: 12.015

9.  Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function.

Authors:  Marie Björnholm; Heike Münzberg; Rebecca L Leshan; Eneida C Villanueva; Sarah H Bates; Gwendolyn W Louis; Justin C Jones; Ryoko Ishida-Takahashi; Christian Bjørbaek; Martin G Myers
Journal:  J Clin Invest       Date:  2007-04-05       Impact factor: 14.808

10.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  15 in total

Review 1.  Neuroendocrine microRNAs linked to energy homeostasis: future therapeutic potential.

Authors:  Kimberly W Y Mak; Aws F Mustafa; Denise D Belsham
Journal:  Pharmacol Rep       Date:  2022-09-09       Impact factor: 3.919

2.  Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period.

Authors:  Xiaoliang Qiu; Hoangha Dao; Mengjie Wang; Amelia Heston; Kaitlyn M Garcia; Alisha Sangal; Abigail R Dowling; Latrice D Faulkner; Scott C Molitor; Carol F Elias; Jennifer W Hill
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 3.  Possible Integrative Actions of Leptin and Insulin Signaling in the Hypothalamus Targeting Energy Homeostasis.

Authors:  Mina Thon; Toru Hosoi; Koichiro Ozawa
Journal:  Front Endocrinol (Lausanne)       Date:  2016-10-20       Impact factor: 5.555

Review 4.  Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.

Authors:  Alexander O Shpakov; Kira V Derkach; Lev M Berstein
Journal:  Future Sci OA       Date:  2015-11-01

5.  Selective Inhibition of Janus Kinase 3 Has No Impact on Infarct Size or Neurobehavioral Outcomes in Permanent Ischemic Stroke in Mice.

Authors:  Kelly M DeMars; Sean C Pacheco; Changjun Yang; David M Siwarski; Eduardo Candelario-Jalil
Journal:  Front Neurol       Date:  2017-07-25       Impact factor: 4.003

6.  Editorial: Leptin Resistance in Metabolic Disorders: Possible Mechanisms and Treatments.

Authors:  Toru Hosoi; Margherita Maffei
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-02       Impact factor: 5.555

Review 7.  The Leptin Receptor Complex: Heavier Than Expected?

Authors:  Joris Wauman; Lennart Zabeau; Jan Tavernier
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-21       Impact factor: 5.555

8.  Leptin induces oncostatin M production in osteoblasts by downregulating miR-93 through the Akt signaling pathway.

Authors:  Wei-Hung Yang; Chun-Hao Tsai; Yi-Chin Fong; Yuan-Li Huang; Shoou-Jyi Wang; Yung-Sen Chang; Chih-Hsin Tang
Journal:  Int J Mol Sci       Date:  2014-09-05       Impact factor: 5.923

9.  Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus.

Authors:  Hiroshi Iwakura; Katsuko Dote; Mika Bando; Hiroyuki Koyama; Kiminori Hosoda; Kenji Kangawa; Kazuwa Nakao
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

10.  Insulin enhanced leptin-induced STAT3 signaling by inducing GRP78.

Authors:  Mina Thon; Toru Hosoi; Koichiro Ozawa
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.